文献速递乳腺癌支持与姑息治疗

乳腺癌幸存者脂肪组织分布与心血管疾病风险

Adipose Tissue Distribution and Cardiovascular Disease Risk Among Breast Cancer Survivors.
PubMed 文献 · J Clin Oncol · 2019-08-01

该研究纳入2943例无心血管疾病史的非转移性乳腺癌患者,利用诊断时CT测量内脏、皮下及肌内脂肪,分析脂肪分布与心血管事件的关系。中位随访6年发生328例心血管事件,内脏及肌内脂肪每增加1个标准差分别与心血管风险升高相关(HR 1.15和1.21),正常体重患者内脏脂肪每增1个标准差风险升高70%(HR 1.70)。

要点

  • 内脏脂肪每增1个标准差,心血管风险HR 1.15(95%CI 1.03-1.29)。
  • 肌内脂肪每增1个标准差,心血管风险HR 1.21(95%CI 1.06-1.37)。
  • 正常体重患者内脏脂肪每增1个标准差,心血管风险HR 1.70(95%CI 1.10-2.62)。

核心结论

  • 乳腺癌诊断后,内脏和肌内脂肪与心血管疾病发生率升高相关,独立于既存心血管危险因素和癌症治疗。
  • 正常体重患者中内脏脂肪增加所致的心血管风险升高无法通过BMI单独识别。
  • 脂肪组织分布测量可能有助于识别高危患者并制定心血管预防策略。

研究设计与样本

  • 研究纳入2943例无心血管疾病史的非转移性乳腺癌患者,平均年龄56(12)岁。
  • 利用诊断附近临床CT测量内脏脂肪面积(cm²)、皮下脂肪面积(cm²)和肌内脂肪(CT值反向评分)。
  • 通过ICD-9/10编码识别非致死性卒中、心肌梗死、心力衰竭或心血管死亡,中位随访6年。
  • 采用竞争风险模型估计脂肪每增加1个标准差的风险比(HR)及95%CI,并校正人口学、吸烟、癌症治疗及既存心血管危险因素。

主要发现

  • 中位随访6年期间共发生328例心血管事件。
  • 内脏脂肪每增加1个标准差,心血管风险HR 1.15(95%CI 1.03-1.29)。
  • 肌内脂肪每增加1个标准差,心血管风险HR 1.21(95%CI 1.06-1.37)。
  • 所有BMI类别中均存在内脏和肌内脂肪过多。
  • 正常体重患者中,内脏脂肪每增加1个标准差,心血管风险HR 1.70(95%CI 1.10-2.62)。

临床怎么用

  • 在乳腺癌 survivorship 管理中,可考虑利用临床CT评估内脏和肌内脂肪分布以辅助心血管风险分层。
  • 对正常体重但内脏脂肪高的患者,不应仅依赖BMI评估心血管风险,需加强预防干预。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Cardiovascular disease (CVD) is a major source of morbidity and mortality among breast cancer survivors. Although body mass index (BMI) is associated with CVD risk, adipose tissue distribution may better identify patients with a high risk of CVD after breast cancer. METHODS: Among 2,943 patients with nonmetastatic breast cancer without prior CVD, we used International Classification of Diseases (9th and 10th revisions) codes to identify incidence of nonfatal stroke, myocardial infarction, heart failure, or CVD death. From clinically acquired computed tomography scans obtained near diagnosis, we measured visceral adiposity (centimeters squared), subcutaneous adiposity (centimeters squared), and intramuscular adiposity (fatty infiltration into muscle [Hounsfield Units, scored inversely]). We estimated hazard ratios (HRs) and 95% CIs per SD increase in adiposity accounting for competing risks and adjusting for demographics, smoking, cancer treatment, and pre-existing CVD risk factors. RESULTS: Mean (SD) age was 56 (12) years. Over a median follow-up of 6 years, 328 CVD events occurred. Each SD increase in visceral or intramuscular adiposity was associated with an increase in CVD risk (HR, 1.15 [95% CI, 1.03 to 1.29] and HR, 1.21 [95% CI, 1.06 to 1.37]), respectively). Excess visceral and intramuscular adiposity occurred across all BMI categories. Among normal-weight patients, each SD greater visceral adiposity increased CVD risk by 70% (HR, 1.70 [95% CI, 1.10 to 2.62]). CONCLUSION: Visceral and intramuscular adiposity were associated with increased CVD incidence after breast cancer diagnosis, independent of pre-existing CVD risk factors and cancer treatments. The increased CVD incidence among normal-weight patients with greater visceral adiposity would go undetected with BMI alone. Measures of adipose tissue distribution may help identify high-risk patients and tailor CVD prevention strategies.

来源:J Clin Oncol,查看原文。版权归原作者所有。

引用

  1. Cespedes Feliciano EM, Chen WY, Bradshaw PT, et al. Adipose Tissue Distribution and Cardiovascular Disease Risk Among Breast Cancer Survivors. J Clin Oncol. 2019. PMID: 31369302. doi:10.1200/JCO.19.00286

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。